Literature DB >> 24285399

Electrospray ionization mass spectrometry probing of binding affinity of berbamine, a flexible cyclic alkaloid from traditional Chinese medicine, with G-quadruplex DNA.

Wei Tan1, Jiang Zhou, Gu Yuan.   

Abstract

RATIONALE: Classic G-quadruplex binders typically have a large aromatic core and interact with G-quadruplexes through π-π stacking with the quartets. There are rather few reports on natural flexible cyclic molecule from traditional Chinese medicine which has high binding affinity with G-quadruplex.
METHODS: Electrospray ionization mass spectrometry (ESI-MS) experiments were performed to evaluate the binding affinities of a natural alkaloid, berbamine, with seven G-quadruplexes. Furthermore, we utilized autodock4 analysis to uncover the binding mode of berbamine with the G-quadruplex.
RESULTS: ESI-MS experiments showed that berbamine has the best binding affinity toward the (GGA)8  G-quadruplex compared with the other six G-quadruplexes. Autodock4 analysis indicated that berbamine interacted with the (GGA)8  G-quadruplex through hydrogen bonding and van der Waals forces with a binding site at the lateral groove formed by DG8-DA9-DA15-DG16.
CONCLUSIONS: In this study, we discovered a novel G-quadruplex binder, berbamine, which has high binding affinity toward the (GGA)8  G-quadruplex. This study provided important clues regarding the probing of small molecule from traditional Chinese medicine which can target the G-quadruplex with high affinity.
Copyright © 2013 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24285399     DOI: 10.1002/rcm.6763

Source DB:  PubMed          Journal:  Rapid Commun Mass Spectrom        ISSN: 0951-4198            Impact factor:   2.419


  7 in total

1.  Berbamine inhibited the growth of prostate cancer cells in vivo and in vitro via triggering intrinsic pathway of apoptosis.

Authors:  Y Zhao; J J Lv; J Chen; X B Jin; M W Wang; Z H Su; L Y Wang; H Y Zhang
Journal:  Prostate Cancer Prostatic Dis       Date:  2016-07-19       Impact factor: 5.554

2.  An In Vitro Study of Aromatic Stacking of Drug Molecules.

Authors:  Shelley N Jackson; Damon C Barbacci; Antonello Bonci; Amina S Woods
Journal:  J Am Soc Mass Spectrom       Date:  2019-04-04       Impact factor: 3.109

3.  Berbamine induces SMMC-7721 cell apoptosis via upregulating p53, downregulating survivin expression and activating mitochondria signaling pathway.

Authors:  Ying Cao; Jianbo Cao; Binbin Yu; Shusheng Wang; Lili Liu; Li Tao; Wanping Sun
Journal:  Exp Ther Med       Date:  2017-12-15       Impact factor: 2.447

4.  In-Depth Bioinformatic Analyses of Nidovirales Including Human SARS-CoV-2, SARS-CoV, MERS-CoV Viruses Suggest Important Roles of Non-canonical Nucleic Acid Structures in Their Lifecycles.

Authors:  Martin Bartas; Václav Brázda; Natália Bohálová; Alessio Cantara; Adriana Volná; Tereza Stachurová; Kateřina Malachová; Eva B Jagelská; Otília Porubiaková; Jiří Červeň; Petr Pečinka
Journal:  Front Microbiol       Date:  2020-07-03       Impact factor: 5.640

5.  Berbamine Suppresses the Progression of Bladder Cancer by Modulating the ROS/NF-κB Axis.

Authors:  Chenglin Han; Zilong Wang; Shuxiao Chen; Lin Li; Yingkun Xu; Weiting Kang; Chunxiao Wei; Hongbin Ma; Muwen Wang; Xunbo Jin
Journal:  Oxid Med Cell Longev       Date:  2021-01-13       Impact factor: 6.543

6.  Combining Electrospray Mass Spectrometry (ESI-MS) and Computational Techniques in the Assessment of G-Quadruplex Ligands: A Hybrid Approach to Optimize Hit Discovery.

Authors:  Giovanni Ribaudo; Alberto Ongaro; Erika Oselladore; Maurizio Memo; Alessandra Gianoncelli
Journal:  J Med Chem       Date:  2021-09-12       Impact factor: 7.446

7.  Synthesis, Binding and Antiviral Properties of Potent Core-Extended Naphthalene Diimides Targeting the HIV-1 Long Terminal Repeat Promoter G-Quadruplexes.

Authors:  Rosalba Perrone; Filippo Doria; Elena Butovskaya; Ilaria Frasson; Silvia Botti; Matteo Scalabrin; Sara Lago; Vincenzo Grande; Matteo Nadai; Mauro Freccero; Sara N Richter
Journal:  J Med Chem       Date:  2015-12-08       Impact factor: 7.446

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.